DONATE

IBEC Seminar: Martijn Gloerich

Mechanical control of cell division Martijn Gloerich, UMC Utrecth, Center for Molecular Medicine, Molecular Cancer Research During development and adult tissue homeostasis, cellular behavior is controlled by signals that cells … Read more

IBEC Seminar: Martijn Gloerich

Mechanical control of cell division Martijn Gloerich, UMC Utrecth, Center for Molecular Medicine, Molecular Cancer Research During development and adult tissue homeostasis, cellular behavior is controlled by signals that cells … Read more

IBEC Seminar: Martijn Gloerich

Mechanical control of cell division Martijn Gloerich, UMC Utrecth, Center for Molecular Medicine, Molecular Cancer Research During development and adult tissue homeostasis, cellular behavior is controlled by signals that cells … Read more

Great success of the Mechanobiology of Cancer Summer School 2019 organised by the Mechano·Control project

More than 60 people attended the “Mechanobiology of Cancer Summer School 2019” organised by IBEC as the center is in charge of coordinating the Mechano·contorl project. The summer school was held in Prullans, a tiny village located at the Catalan Pyrinees between 17 and 21 of September. The event was a great success both in participation and scientific level. The aim of the summer school was to provide training on mechanobiology, and specifically its application to breast cancer, and promote interactions between professionals of the field.

The school included lectures as well as practical workshops in different techniques and disciplines, ranging from modelling to biomechanics to cancer biology. The Mechano·Control project, coordinated by Pere Roca-Cusachs, principal investigator of the IBEC is the largest European project coordinated by the IBEC to date.

Researchers perform thousands of mutations to understand amyotrophic lateral sclerosis

Researchers from IBEC and CRG in Barcelona use a technique called high-throughput mutagenesis to study Amyotrophic Lateral Sclerosis (ALS), with unexpected results.

Results showed that aggregation of TDP-43 is not harmful but actually protects cells, changing our understanding of ALS and opening the door to radically new therapeutic approaches.

Amyotrophic lateral sclerosis (ALS) is a devastating and incurable nervous system disease that affects nerve cells in the brain and spinal cord, causing loss of muscle control and normally death within a few years of diagnosis. In ALS, like in other neurodegenerative diseases, specific protein aggregates have long been recognized as the pathological hallmarks, but it is not clear whether they represent the actual cause of the disease. Indeed, alleviating aggregation has repeatedly failed as a therapeutic strategy when trying to treat neurodegenerative diseases such as Alzheimer’s disease.

SEMINAR Series in Development, Regeneration and Disease

“Engineering human pluripotent stem cells for organoid applications in regenerative medicine” Nuria Montserrat Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. Pluripotency for Organ Regeneration, Institute for Bioengineering of … Read more

SEMINAR Series in Development, Regeneration and Disease

“Engineering human pluripotent stem cells for organoid applications in regenerative medicine” Nuria Montserrat Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. Pluripotency for Organ Regeneration, Institute for Bioengineering of … Read more

SEMINAR Series in Development, Regeneration and Disease

“Engineering human pluripotent stem cells for organoid applications in regenerative medicine” Nuria Montserrat Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. Pluripotency for Organ Regeneration, Institute for Bioengineering of … Read more

SEMINAR Series in Development, Regeneration and Disease

“Engineering human pluripotent stem cells for organoid applications in regenerative medicine” Nuria Montserrat Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. Pluripotency for Organ Regeneration, Institute for Bioengineering of … Read more